CNS Summit 2022 Abstracts of Poster Presentations
A message from the editor Dear Colleagues: Welcome to the [...]
CNS Summit 2021 Abstracts of Poster Presentations
A message from the editor Dear Colleagues: Welcome to the [...]
CNS Summit 2020 Abstracts of Poster Presentations
A message from the editor Dear Colleagues: Welcome to the [...]
Do Patterns of Instability or Severity of Psychopathology During Screening Predict Relapse in Schizophrenic Outpatient Subjects with Moderate to Severe Negative Symptoms Assigned to Placebo?
by David G. Daniel, MD; Alan Kott, MD; Jay Saoud, [...]
The Effect of Acutely Administered Propofol on Forced Swim Test Outcomes in Mice
by David G. Daniel, MD; Noah G. Daniel; Donald T. [...]
Correlation Between the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale and Nonmotor Scales in Patients with Parkinson’s Disease
by Erika D. Driver-Dunckley, MD; Nan Zhang, MS; Holly A. [...]
CNS Summit 2019 Abstracts of Poster Presentations
A message from the editor: Dear Colleagues: Welcome to the [...]
Is High Placebo Response Really a Problem in Depression Trials? A Critical Re-analysis of Depression Studies
by Mark E. Whitlock, PhD; Philip W. Woodward, MPhil; and [...]
Letter to the Editor: The Click-through Rate as a Measure of Dementia Health Promotion on YouTube
Dear Editor: Social media platforms are increasingly used to disseminate [...]
Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study
by Leslie Citrome, MD, MPH; Stephanie S. O’Malley, PhD; David [...]